Literature DB >> 15534863

Thrombin peptide (TP508) treatment of rat growth plate cartilage cells promotes proliferation and retention of the chondrocytic phenotype while blocking terminal endochondral differentiation.

Z Schwartz1, D H Carney, R S Crowther, J T Ryaby, B D Boyan.   

Abstract

A synthetic peptide representing the receptor-binding domain of human thrombin (TP508, also known as Chrysalin) accelerates fracture repair in rats via endochondral ossification and promotes repair of rabbit cartilage defects. To understand how this peptide might stimulate cartilage and bone formation, we employed an established in vitro model of growth plate cartilage regulation. Rat costochondral cartilage resting zone and growth zone chondrocytes were treated with 0, 0.07, 0.7, or 7 microg/ml TP508 or a scrambled peptide, TP508-SP. Proliferation ([3H]-thymidine incorporation) was examined in pre-confluent cultures; effects on cell number, alkaline phosphatase activity, [35S]-sulfate incorporation, and responsiveness to vitamin D metabolites were tested using confluent cultures. TP508 did not affect proliferation of resting zone cells but it caused a dose-dependent increase in cell number and DNA synthesis of growth zone cells. Alkaline phosphatase specific activity of resting zone cells was reduced by TP508, whereas [35S]-sulfate incorporation was increased. Neither parameter was affected in growth zone cell cultures. TP508 treatment for 24 h did not induce resting zone cells to respond to 1alpha,25(OH)2D3, either with respect to alkaline phosphatase activity or proteoglycan production. In contrast, TP508 treatment reduced the stimulatory effect of 24R,25(OH)2D3 on alkaline phosphatase but it did not alter the stimulatory effect of 24R,25(OH)2D3 on [35S]-sulfate incorporation. In cultures treated for 48, 72, or 140 h with TP508, 1alpha,25(OH)2D3 restored alkaline phosphatase activity to control levels but did not stimulate activity over levels observed in untreated control cultures. The stimulatory effect of TP508 on [35S]-sulfate incorporation was evident up to 48 h post-confluence but at later time points, proteoglycan production was comparable to that seen in control cultures, control cultures challenged with 1alpha,25(OH)2D3, and cultures treated with TP508 followed by 1alpha,25(OH)2D3. TP508-SP had no effect on any of the parameters tested. These results indicate that TP508 exerts maturation specific effects on chondrocytes in the endochondral lineage, promoting cartilage extracellular matrix synthesis over endochondral differentiation in resting zone cells and proliferation over differentiation of growth zone cells. 2004 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15534863     DOI: 10.1002/jcp.20145

Source DB:  PubMed          Journal:  J Cell Physiol        ISSN: 0021-9541            Impact factor:   6.384


  4 in total

1.  B2A peptide induces chondrogenic differentiation in vitro and enhances cartilage repair in rats.

Authors:  Xinhua Lin; Shobana Shanmugasundaram; Yi Liu; Alexandrine Derrien; Maria Nurminskaya; Paul O Zamora
Journal:  J Orthop Res       Date:  2012-01-23       Impact factor: 3.494

2.  Evaluation of early osteochondral defect repair in a rabbit model utilizing fourier transform-infrared imaging spectroscopy, magnetic resonance imaging, and quantitative T2 mapping.

Authors:  Minwook Kim; Li F Foo; Christopher Uggen; Steven Lyman; James T Ryaby; Daniel P Moynihan; Daniel Anthony Grande; Hollis G Potter; Nancy Pleshko
Journal:  Tissue Eng Part C Methods       Date:  2010-06       Impact factor: 3.056

3.  Thrombin related peptide TP508 promoted fracture repair in a mouse high energy fracture model.

Authors:  Brain M Hanratty; James T Ryaby; Xiao-Hua Pan; Gang Li
Journal:  J Orthop Surg Res       Date:  2009-01-29       Impact factor: 2.359

4.  Novel regenerative peptide TP508 mitigates radiation-induced gastrointestinal damage by activating stem cells and preserving crypt integrity.

Authors:  Carla Kantara; Stephanie M Moya; Courtney W Houchen; Shahid Umar; Robert L Ullrich; Pomila Singh; Darrell H Carney
Journal:  Lab Invest       Date:  2015-08-17       Impact factor: 5.662

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.